Nabasca, Kaye .

HRN: 19-62-90  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2025
CEFUROXIME 500MG (TAB)
06/22/2025
06/22/2025
IV
1.5gm PTOR
PTOR
Preop Prophylaxis
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: